Viridian Therapeutics
VRDN
VRDN
169 hedge funds and large institutions have $1.32B invested in Viridian Therapeutics in 2025 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 61 increasing their positions, 64 reducing their positions, and 28 closing their positions.
Holders
169
Holders Change
-7
Holders Change %
-3.98%
% of All Funds
2.27%
Holding in Top 10
10
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
22
Increased
61
Reduced
64
Closed
28
Calls
$1.81M
Puts
$2.72M
Net Calls
-$912K
Net Calls Change
-$1.82M
Top Buyers
| 1 |
BBA
1
Baker Bros. Advisors
New York
|
$24.4M |
| 2 |
CC
2
Commodore Capital
New York
|
$68.2M |
| 3 |
3
T. Rowe Price Associates
Baltimore,
Maryland
|
$40.5M |
| 4 |
PBA
4
Paradigm Biocapital Advisors
New York
|
$38.3M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$9.08M |
